{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:11:32Z","timestamp":1784718692730,"version":"3.55.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioData Mining"],"DOI":"10.1186\/s13040-025-00475-4","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T07:12:33Z","timestamp":1756105953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mapping the evolving trend of research on efferocytosis: a comprehensive data-mining-based study"],"prefix":"10.1186","volume":"18","author":[{"given":"Yanpeng","family":"Jian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijia","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"475_CR1","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.3389\/fimmu.2017.01863","volume":"8","author":"N Karaji","year":"2017","unstructured":"Karaji N, Sattentau QJ. Efferocytosis of Pathogen-Infected cells. Front Immunol. 2017;8:1863.","journal-title":"Front Immunol"},{"issue":"8","key":"475_CR2","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41573-022-00470-y","volume":"21","author":"P Mehrotra","year":"2022","unstructured":"Mehrotra P, Ravichandran KS. Drugging the efferocytosis process: concepts and opportunities. Nat Rev Drug Discov. 2022;21(8):601\u201320.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"475_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12964-020-00542-9","volume":"18","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Yao Y, Deng Y, et al. Regulation of efferocytosis as a novel cancer therapy. Cell Commun Signal. 2020;18(1):71.","journal-title":"Cell Commun Signal"},{"issue":"11","key":"475_CR4","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1016\/j.cmet.2021.08.001","volume":"33","author":"A Trzeciak","year":"2021","unstructured":"Trzeciak A, Wang YT, Perry JSA. First we eat, then we do everything else: the dynamic metabolic regulation of efferocytosis. Cell Metab. 2021;33(11):2126\u201341.","journal-title":"Cell Metab"},{"key":"475_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1146\/annurev-pharmtox-032723-110507","volume":"64","author":"IKH Poon","year":"2024","unstructured":"Poon IKH, Ravichandran KS. Targeting efferocytosis in inflammaging. Annu Rev Pharmacol Toxicol. 2024;64:339\u201357.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"475_CR6","doi-asserted-by":"publisher","first-page":"1332482","DOI":"10.3389\/fcell.2023.1332482","volume":"11","author":"G Hou","year":"2024","unstructured":"Hou G, Wang X, Wang A, et al. The role of secreted proteins in efferocytosis. Front Cell Dev Biol. 2024;11:1332482.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"475_CR7","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.1038\/s41467-020-19272-0","volume":"11","author":"H Moon","year":"2020","unstructured":"Moon H, Min C, Kim G, et al. Crbn modulates calcium influx by regulating Orai1 during efferocytosis. Nat Commun. 2020;11(1):5489.","journal-title":"Nat Commun"},{"issue":"6","key":"475_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41419-023-05925-7","volume":"14","author":"S Yang","year":"2023","unstructured":"Yang S, Min C, Moon H, et al. Internalization of apoptotic cells during efferocytosis requires Mertk-mediated calcium influx. Cell Death Dis. 2023;14(6):391.","journal-title":"Cell Death Dis"},{"key":"475_CR9","doi-asserted-by":"publisher","first-page":"1524058","DOI":"10.3389\/fimmu.2025.1524058","volume":"16","author":"YQ Liu","year":"2025","unstructured":"Liu YQ, Li ZZ, Han YL, et al. The role of efferocytosis in inflammatory bowel disease. Front Immunol. 2025;16:1524058.","journal-title":"Front Immunol"},{"issue":"6","key":"475_CR10","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1080\/15548627.2024.2311548","volume":"20","author":"MY Wu","year":"2024","unstructured":"Wu MY, Wang EJ, Ye RD, et al. Enhancement of LC3-associated efferocytosis for the alleviation of intestinal inflammation. Autophagy. 2024;20(6):1442\u20133.","journal-title":"Autophagy"},{"issue":"7","key":"475_CR11","doi-asserted-by":"publisher","first-page":"e28399","DOI":"10.1016\/j.heliyon.2024.e28399","volume":"10","author":"Q Li","year":"2024","unstructured":"Li Q, Liu H, Yin G, et al. Efferocytosis: current status and future prospects in the treatment of autoimmune diseases. Heliyon. 2024;10(7):e28399.","journal-title":"Heliyon"},{"key":"475_CR12","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3389\/fimmu.2018.01645","volume":"9","author":"F Abdolmaleki","year":"2018","unstructured":"Abdolmaleki F, Farahani N, Gheibi Hayat SM, et al. The role of efferocytosis in autoimmune diseases. Front Immunol. 2018;9:1645.","journal-title":"Front Immunol"},{"key":"475_CR13","doi-asserted-by":"publisher","first-page":"1533571","DOI":"10.3389\/fphar.2025.1533571","volume":"16","author":"X He","year":"2025","unstructured":"He X, Cheng X, Zhang Z, et al. Efferocytosis-related gene IL33 predicts prognosis and immune response and mediates proliferation and migration in vitro and in vivo of breast cancer. Front Pharmacol. 2025;16:1533571.","journal-title":"Front Pharmacol"},{"issue":"1","key":"475_CR14","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1038\/s41467-024-46735-5","volume":"15","author":"M Cheng","year":"2024","unstructured":"Cheng M, Chen S, Li K, et al. CD276-dependent efferocytosis by tumor-associated macrophages promotes immune evasion in bladder cancer. Nat Commun. 2024;15(1):2818.","journal-title":"Nat Commun"},{"issue":"5","key":"475_CR15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41419-024-06705-7","volume":"15","author":"R Grazda","year":"2024","unstructured":"Grazda R, Seyfried AN, Maddipati KR, et al. Resolvin E1 improves efferocytosis and rescues severe aplastic anemia in mice. Cell Death Dis. 2024;15(5):324.","journal-title":"Cell Death Dis"},{"issue":"3","key":"475_CR16","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s12975-024-01255-8","volume":"16","author":"J Yuan","year":"2025","unstructured":"Yuan J, Liao YS, Zhang TC, et al. Integrating bulk RNA and Single-Cell sequencing data unveils efferocytosis patterns and CeRNA network in ischemic stroke. Transl Stroke Res. 2025;16(3):733\u201346.","journal-title":"Transl Stroke Res"},{"key":"475_CR17","doi-asserted-by":"publisher","first-page":"1498503","DOI":"10.3389\/fmed.2025.1498503","volume":"12","author":"X Cao","year":"2025","unstructured":"Cao X, Li F, Xie X, et al. Efferocytosis and inflammation: a bibliometric and systematic analysis. Front Med (Lausanne). 2025;12:1498503.","journal-title":"Front Med (Lausanne)"},{"issue":"39","key":"475_CR18","doi-asserted-by":"publisher","first-page":"e34366","DOI":"10.1097\/MD.0000000000034366","volume":"102","author":"L Hu","year":"2023","unstructured":"Hu L, Lv Z, Gu Y, et al. A bibliometric analysis of efferocytosis in cardiovascular diseases from 2001 to 2022. Med (Baltim). 2023;102(39):e34366.","journal-title":"Med (Baltim)"},{"issue":"1","key":"475_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s40246-024-00687-5","volume":"18","author":"Y Lyu","year":"2024","unstructured":"Lyu Y, Zhao H, Zeng G, et al. Mapping the evolving trend of research on leukocyte telomere length: a text-mining study. Hum Genomics. 2024;18(1):117.","journal-title":"Hum Genomics"},{"issue":"12","key":"475_CR20","doi-asserted-by":"publisher","first-page":"8734","DOI":"10.21037\/qims-24-128","volume":"14","author":"H Wu","year":"2024","unstructured":"Wu H, Cheng K, Sun Z, et al. Trends of mapping knowledge structure and themes of cancer sonodynamic therapy: a text-mining study. Quant Imaging Med Surg. 2024;14(12):8734\u201357.","journal-title":"Quant Imaging Med Surg"},{"issue":"4","key":"475_CR21","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1097\/JS9.0000000000001049","volume":"110","author":"K Cheng","year":"2024","unstructured":"Cheng K, Li Z, Sun Z, et al. The rapid growth of bibliometric studies: a call for international guidelines. Int J Surg. 2024;110(4):2446\u20138.","journal-title":"Int J Surg"},{"key":"475_CR22","doi-asserted-by":"publisher","first-page":"1302016","DOI":"10.3389\/fmolb.2023.1302016","volume":"10","author":"K Cheng","year":"2023","unstructured":"Cheng K, Li W, Wu H, et al. Mapping knowledge structure and themes trends of cancer-associated fibroblasts: a text-mining study. Front Mol Biosci. 2023;10:1302016.","journal-title":"Front Mol Biosci"},{"key":"475_CR23","doi-asserted-by":"publisher","first-page":"1048211","DOI":"10.3389\/fphar.2022.1048211","volume":"13","author":"Z Wu","year":"2023","unstructured":"Wu Z, Cheng K, Shen Z, et al. Mapping knowledge landscapes and emerging trends of sonodynamic therapy: A bibliometric and visualized study. Front Pharmacol. 2023;13:1048211.","journal-title":"Front Pharmacol"},{"issue":"2","key":"475_CR24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","volume":"84","author":"NJ van Eck","year":"2010","unstructured":"van Eck NJ, Waltman L. Software survey: vosviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523\u201338.","journal-title":"Scientometrics"},{"key":"475_CR25","unstructured":"Synnestvedt MB, Chen C, Holmes JH. CiteSpace II: visualization and knowledge discovery in bibliographic databases. AMIA Annu Symp Proc 2005:724\u20138."},{"key":"475_CR26","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.2147\/JMDH.S437127","volume":"16","author":"Z Liu","year":"2023","unstructured":"Liu Z, Li Z, Wang L, et al. Bibliometric analysis of the knowledge landscape of periodontal disease in pregnancy: A noteworthy multidisciplinary issue. J Multidiscip Healthc. 2023;16:3941\u201357.","journal-title":"J Multidiscip Healthc"},{"issue":"1","key":"475_CR27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12967-022-03615-0","volume":"20","author":"Z Shen","year":"2022","unstructured":"Shen Z, Hu J, Wu H, et al. Global research trends and foci of artificial intelligence-based tumor pathology: a scientometric study. J Transl Med. 2022;20(1):409.","journal-title":"J Transl Med"},{"issue":"2","key":"475_CR28","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/asi.22968","volume":"65","author":"C Chen","year":"2014","unstructured":"Chen C, Leydesdorff L. Patterns of connections and movements in dual-map overlays: A new method of publication portfolio analysis. J Association Inform Sci Technol. 2014;65(2):334\u201351.","journal-title":"J Association Inform Sci Technol"},{"key":"475_CR29","doi-asserted-by":"crossref","unstructured":"Wu H, Sun Z, Zeng G et al. Mapping knowledge structure and themes trends of ewing sarcoma: A Text-Mining study. Ann Surg Oncol. 2025.","DOI":"10.1245\/s10434-025-16978-7"},{"issue":"12","key":"475_CR30","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.2174\/138945007783220623","volume":"8","author":"I Tabas","year":"2007","unstructured":"Tabas I. Apoptosis and efferocytosis in mouse models of atherosclerosis. Curr Drug Targets. 2007;8(12):1288\u201396.","journal-title":"Curr Drug Targets"},{"issue":"1","key":"475_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4049\/jimmunol.1301945","volume":"193","author":"LK McCauley","year":"2014","unstructured":"McCauley LK, Dalli J, Koh AJ, et al. Cutting edge: parathyroid hormone facilitates macrophage efferocytosis in bone marrow via proresolving mediators resolvin D1 and resolvin D2. J Immunol. 2014;193(1):26\u20139.","journal-title":"J Immunol"},{"issue":"15","key":"475_CR32","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1182\/blood-2012-04-423525","volume":"120","author":"J Dalli","year":"2012","unstructured":"Dalli J, Serhan CN. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood. 2012;120(15):e60\u201372.","journal-title":"Blood"},{"issue":"21","key":"475_CR33","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1016\/j.neuron.2022.10.015","volume":"110","author":"C Romero-Molina","year":"2022","unstructured":"Romero-Molina C, Garretti F, Andrews SJ, et al. Microglial efferocytosis: diving into the alzheimer\u2019s disease gene pool. Neuron. 2022;110(21):3513\u201333.","journal-title":"Neuron"},{"key":"475_CR34","doi-asserted-by":"publisher","first-page":"106857","DOI":"10.1016\/j.nbd.2025.106857","volume":"207","author":"H Zang","year":"2025","unstructured":"Zang H, Ji X, Yao W, et al. Role of efferocytosis in chronic pain -- from molecular perspective. Neurobiol Dis. 2025;207:106857.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"475_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.immuni.2013.11.019","volume":"40","author":"S Epelman","year":"2014","unstructured":"Epelman S, Lavine KJ, Beaudin AE, et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity. 2014;40(1):91\u2013104.","journal-title":"Immunity"},{"issue":"7","key":"475_CR36","first-page":"389","volume":"16","author":"M B\u00e4ck","year":"2019","unstructured":"B\u00e4ck M, Yurdagul A Jr, Tabas I, et al. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol. 2019;16(7):389\u2013406.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"475_CR37","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/imr.12266","volume":"264","author":"G Weiss","year":"2015","unstructured":"Weiss G, Schaible UE. Macrophage defense mechanisms against intracellular bacteria. Immunol Rev. 2015;264(1):182\u2013203.","journal-title":"Immunol Rev"},{"issue":"3","key":"475_CR38","first-page":"187","volume":"38","author":"M Horckmans","year":"2017","unstructured":"Horckmans M, Ring L, Duchene J, et al. Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype. Eur Heart J. 2017;38(3):187\u201397.","journal-title":"Eur Heart J"},{"issue":"5","key":"475_CR39","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/emmm.201202382","volume":"5","author":"A Ortega-G\u00f3mez","year":"2013","unstructured":"Ortega-G\u00f3mez A, Perretti M, Soehnlein O. Resolution of inflammation: an integrated view. EMBO Mol Med. 2013;5(5):661\u201374.","journal-title":"EMBO Mol Med"},{"issue":"4","key":"475_CR40","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","volume":"20","author":"AC Doran","year":"2020","unstructured":"Doran AC, Yurdagul A Jr, Tabas I. Efferocytosis in health and disease. Nat Rev Immunol. 2020;20(4):254\u201367.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"475_CR41","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cmet.2012.01.022","volume":"15","author":"X Liao","year":"2012","unstructured":"Liao X, Sluimer JC, Wang Y, et al. Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab. 2012;15(4):545\u201353.","journal-title":"Cell Metab"},{"issue":"6","key":"475_CR42","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/cdd.2016.11","volume":"23","author":"RB Birge","year":"2016","unstructured":"Birge RB, Boeltz S, Kumar S, et al. Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer. Cell Death Differ. 2016;23(6):962\u201378.","journal-title":"Cell Death Differ"},{"issue":"3","key":"475_CR43","doi-asserted-by":"publisher","first-page":"e9539","DOI":"10.1371\/journal.pone.0009539","volume":"5","author":"S Khanna","year":"2010","unstructured":"Khanna S, Biswas S, Shang Y, et al. Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS ONE. 2010;5(3):e9539.","journal-title":"PLoS ONE"},{"issue":"7","key":"475_CR44","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41580-020-0232-1","volume":"21","author":"E Boada-Romero","year":"2020","unstructured":"Boada-Romero E, Martinez J, Heckmann BL, et al. The clearance of dead cells by efferocytosis. Nat Rev Mol Cell Biol. 2020;21(7):398\u2013414.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"475_CR45","doi-asserted-by":"publisher","first-page":"101178","DOI":"10.1016\/j.mtbio.2024.101178","volume":"28","author":"Q Xia","year":"2024","unstructured":"Xia Q, Liu F, Zhou Y, et al. CD47-SIRP\u03b1 signaling-inspired engineered monocytes for preventing the progression of atherosclerotic plaques. Mater Today Bio. 2024;28:101178.","journal-title":"Mater Today Bio"},{"issue":"2","key":"475_CR46","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s10555-025-10269-z","volume":"44","author":"A Ooki","year":"2025","unstructured":"Ooki A, Osumi H, Shimozaki K, et al. Novel immunotherapy for gastric cancer: targeting the CD47-SIRP\u03b1 axis. Cancer Metastasis Rev. 2025;44(2):52.","journal-title":"Cancer Metastasis Rev"},{"key":"475_CR47","first-page":"81","volume":"13","author":"HJ Kim","year":"2020","unstructured":"Kim HJ, Trinh NT, Choi Y, et al. ADAM17 genetic variants and the response of TNF-\u03b1 inhibitor in rheumatoid arthritis patients. Pharmgenomics Pers Med. 2020;13:81\u20138.","journal-title":"Pharmgenomics Pers Med"},{"issue":"5","key":"475_CR48","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1189\/jlb.3A0515-207R","volume":"99","author":"I Yan","year":"2016","unstructured":"Yan I, Schwarz J, L\u00fccke K, et al. ADAM17 controls IL-6 signaling by cleavage of the murine IL-6R\u03b1 from the cell surface of leukocytes during inflammatory responses. J Leukoc Biol. 2016;99(5):749\u201360.","journal-title":"J Leukoc Biol"},{"issue":"5","key":"475_CR49","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.jaci.2015.07.034","volume":"136","author":"RF Fernandez-Boyanapalli","year":"2015","unstructured":"Fernandez-Boyanapalli RF, Falcone EL, Zerbe CS, et al. Impaired efferocytosis in human chronic granulomatous disease is reversed by Pioglitazone treatment. J Allergy Clin Immunol. 2015;136(5):1399\u2013e14013.","journal-title":"J Allergy Clin Immunol"},{"issue":"29","key":"475_CR50","doi-asserted-by":"publisher","first-page":"e2308325","DOI":"10.1002\/advs.202308325","volume":"11","author":"R Han","year":"2024","unstructured":"Han R, Ren Z, Wang Q, et al. Synthetic biomimetic liposomes Harness efferocytosis machinery for highly efficient Macrophages-Targeted drug delivery to alleviate inflammation. Adv Sci (Weinh). 2024;11(29):e2308325.","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"475_CR51","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/s42255-023-00921-9","volume":"5","author":"D Ngai","year":"2023","unstructured":"Ngai D, Schilperoort M, Tabas I. Efferocytosis-induced lactate enables the proliferation of pro-resolving macrophages to mediate tissue repair. Nat Metab. 2023;5(12):2206\u201319.","journal-title":"Nat Metab"},{"issue":"6","key":"475_CR52","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.bcp.2013.07.002","volume":"86","author":"HN Lee","year":"2013","unstructured":"Lee HN, Surh YJ. Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis. Biochem Pharmacol. 2013;86(6):759\u201369.","journal-title":"Biochem Pharmacol"},{"issue":"Pt 17","key":"475_CR53","first-page":"4037","volume":"126","author":"HN Lee","year":"2013","unstructured":"Lee HN, Kundu JK, Cha YN, et al. Resolvin D1 stimulates efferocytosis through p50\/p50-mediated suppression of tumor necrosis factor-\u03b1 expression. J Cell Sci. 2013;126(Pt 17):4037\u201347.","journal-title":"J Cell Sci"},{"key":"475_CR54","doi-asserted-by":"publisher","first-page":"1275203","DOI":"10.3389\/fimmu.2024.1275203","volume":"15","author":"YR Sheng","year":"2024","unstructured":"Sheng YR, Hu WT, Chen S, et al. Efferocytosis by macrophages in physiological and pathological conditions: regulatory pathways and molecular mechanisms. Front Immunol. 2024;15:1275203.","journal-title":"Front Immunol"},{"key":"475_CR55","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.mib.2013.10.007","volume":"17","author":"CJ Martin","year":"2014","unstructured":"Martin CJ, Peters KN, Behar SM. Macrophages clean up: efferocytosis and microbial control. Curr Opin Microbiol. 2014;17:17\u201323.","journal-title":"Curr Opin Microbiol"},{"key":"475_CR56","doi-asserted-by":"publisher","first-page":"767630","DOI":"10.3389\/fimmu.2022.767630","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang W, Xu Y, et al. Extracellular HMGB1 impairs Macrophage-Mediated efferocytosis by suppressing the Rab43-Controlled cell surface transport of CD91. Front Immunol. 2022;13:767630.","journal-title":"Front Immunol"},{"issue":"9","key":"475_CR57","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.4049\/jimmunol.1101500","volume":"187","author":"S Banerjee","year":"2011","unstructured":"Banerjee S, de Freitas A, Friggeri A, et al. Intracellular HMGB1 negatively regulates efferocytosis. J Immunol. 2011;187(9):4686\u201394.","journal-title":"J Immunol"},{"key":"475_CR58","doi-asserted-by":"publisher","first-page":"156579","DOI":"10.1016\/j.phymed.2025.156579","volume":"140","author":"X He","year":"2025","unstructured":"He X, Li Z, Li S, et al. Huoxue Tongluo tablet enhances atherosclerosis efferocytosis by promoting the differentiation of Trem2\u2009+\u2009macrophages via PPAR\u03b3 signaling pathway. Phytomedicine. 2025;140:156579.","journal-title":"Phytomedicine"},{"issue":"5","key":"475_CR59","doi-asserted-by":"publisher","first-page":"e173832","DOI":"10.1172\/jci.insight.173832","volume":"9","author":"X Wang","year":"2024","unstructured":"Wang X, Du W, Li Y, et al. Macrophage-enriched Sectm1a promotes efficient efferocytosis to attenuate ischemia\/reperfusion-induced cardiac injury. JCI Insight. 2024;9(5):e173832.","journal-title":"JCI Insight"},{"key":"475_CR60","doi-asserted-by":"crossref","unstructured":"Li L, Li G, Zhai W. Single-cell transcriptomic analysis reveals efferocytosis signature predicting immunotherapy response in hepatocellular carcinoma. Dig Liver Dis. 2025.","DOI":"10.1016\/j.dld.2025.01.196"},{"key":"475_CR61","doi-asserted-by":"publisher","first-page":"1218244","DOI":"10.3389\/fphar.2023.1218244","volume":"14","author":"K Xu","year":"2023","unstructured":"Xu K, Liu Y, Luo H, et al. Efferocytosis signatures as prognostic markers for revealing immune landscape and predicting immunotherapy response in hepatocellular carcinoma. Front Pharmacol. 2023;14:1218244.","journal-title":"Front Pharmacol"},{"key":"475_CR62","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/bs.ircmb.2021.02.002","volume":"361","author":"L Zhou","year":"2021","unstructured":"Zhou L, Matsushima GK. Tyro3, axl, Mertk receptor-mediated efferocytosis and immune regulation in the tumor environment. Int Rev Cell Mol Biol. 2021;361:165\u2013210.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"12","key":"475_CR63","doi-asserted-by":"publisher","first-page":"7657","DOI":"10.4049\/jimmunol.176.12.7657","volume":"176","author":"K Morimoto","year":"2006","unstructured":"Morimoto K, Janssen WJ, Fessler MB, et al. Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease. J Immunol. 2006;176(12):7657\u201365.","journal-title":"J Immunol"},{"issue":"6","key":"475_CR64","doi-asserted-by":"publisher","first-page":"e2860","DOI":"10.1038\/cddis.2017.260","volume":"8","author":"YJ Lee","year":"2017","unstructured":"Lee YJ, Kim MJ, Yoon YS, et al. Simvastatin treatment boosts benefits of apoptotic cell infusion in murine lung fibrosis. Cell Death Dis. 2017;8(6):e2860.","journal-title":"Cell Death Dis"},{"key":"475_CR65","doi-asserted-by":"publisher","first-page":"108282","DOI":"10.1016\/j.pharmthera.2022.108282","volume":"238","author":"A Tajbakhsh","year":"2022","unstructured":"Tajbakhsh A, Gheibihayat SM, Askari H, et al. Statin-regulated phagocytosis and efferocytosis in physiological and pathological conditions. Pharmacol Ther. 2022;238:108282.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"475_CR66","doi-asserted-by":"publisher","first-page":"e02079","DOI":"10.1128\/JVI.02079-20","volume":"95","author":"L Zhang","year":"2020","unstructured":"Zhang L, Richard AS, Jackson CB, et al. Phosphatidylethanolamine and phosphatidylserine synergize to enhance GAS6\/AXL-Mediated virus infection and efferocytosis. J Virol. 2020;95(2):e02079\u201320.","journal-title":"J Virol"},{"issue":"6","key":"475_CR67","doi-asserted-by":"publisher","first-page":"e2402421","DOI":"10.1002\/adhm.202402421","volume":"14","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhang LF, Zhang JJ, et al. Spontaneous inflammation resolution inspired nanoparticles promote neutrophil apoptosis and macrophage efferocytosis for acute respiratory distress syndrome treatment. Adv Healthc Mater. 2025;14(6):e2402421.","journal-title":"Adv Healthc Mater"},{"issue":"19","key":"475_CR68","doi-asserted-by":"publisher","first-page":"e2308377","DOI":"10.1002\/adma.202308377","volume":"36","author":"ST Chuang","year":"2024","unstructured":"Chuang ST, Stein JB, Nevins S, et al. Enhancing CAR macrophage efferocytosis via surface engineered lipid nanoparticles targeting LXR signaling. Adv Mater. 2024;36(19):e2308377.","journal-title":"Adv Mater"},{"key":"475_CR69","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jconrel.2024.03.029","volume":"369","author":"X Liu","year":"2024","unstructured":"Liu X, Ou X, Zhang T, et al. In situ neutrophil apoptosis and macrophage efferocytosis mediated by glycyrrhiza protein nanoparticles for acute inflammation therapy. J Control Release. 2024;369:215\u201330.","journal-title":"J Control Release"},{"issue":"18","key":"475_CR70","doi-asserted-by":"publisher","first-page":"18089","DOI":"10.1021\/acsnano.3c04884","volume":"17","author":"Y Wu","year":"2023","unstructured":"Wu Y, Wang C, Yan Y, et al. Efferocytosis nanoinhibitors to promote secondary necrosis and potentiate the immunogenicity of conventional cancer therapies for improved therapeutic benefits. ACS Nano. 2023;17(18):18089\u2013102.","journal-title":"ACS Nano"},{"key":"475_CR71","doi-asserted-by":"publisher","first-page":"787228","DOI":"10.3389\/fmed.2021.787228","volume":"8","author":"H Wu","year":"2021","unstructured":"Wu H, Cheng K, Guo Q, et al. Mapping knowledge structure and themes trends of osteoporosis in rheumatoid arthritis: A bibliometric analysis. Front Med (Lausanne). 2021;8:787228.","journal-title":"Front Med (Lausanne)"}],"container-title":["BioData Mining"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13040-025-00475-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13040-025-00475-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13040-025-00475-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:35:02Z","timestamp":1757424902000},"score":1,"resource":{"primary":{"URL":"https:\/\/biodatamining.biomedcentral.com\/articles\/10.1186\/s13040-025-00475-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["475"],"URL":"https:\/\/doi.org\/10.1186\/s13040-025-00475-4","relation":{},"ISSN":["1756-0381"],"issn-type":[{"value":"1756-0381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"58"}}